TLDR
- UNH fell 5.2% in morning trading, hitting an intraday low of $378.08
- The ex-dividend date of $2.32 per share falls on September 14, adding near-term selling pressure
- Strong August jobs data has raised rate hike expectations, pressuring managed-care stocks
- CEO Patrick Conway sold 1,169 UNH stock at $390.00 on August 21, reducing his stake by 7.09%
- Analyst consensus remains “Moderate Buy” with an average price target of $456.56
UnitedHealth Group stock dropped 5.2% in morning trading on Wednesday, hitting an intraday low of $378.08 after opening near $405. The move extends a broader pullback from its 52-week high of $461.62 reached during the summer.
UnitedHealth Group Incorporated, UNH
The stock has been cooling since July, and today’s session reflects a mix of valuation concerns, macro pressure, and dividend mechanics all hitting at once.
One near-term factor is the approaching ex-dividend date. UNH will pay a $2.32 quarterly dividend, with the record date set for September 14. Dividend-capture traders exiting their positions ahead of that date are adding to the selling pressure.
Macro Headwinds Adding Pressure
Strong August nonfarm payrolls data released earlier this month pushed up expectations for further Federal Reserve rate tightening. That backdrop historically hurts large-cap managed-care names through higher discount rates.
The broader market is also in the red. The S&P 500 was down 0.3% and the Dow Jones fell 0.7%, offering no support for defensive health care names. Peers Elevance Health and Humana face similar cost-trend and reimbursement-rate pressures.
Despite the drop, UNH’s most recent earnings were strong. The company reported $6.38 EPS for Q2 2026, beating the $4.94 consensus estimate by $1.44. Revenue came in at $112.03 billion, topping expectations of $110.81 billion.
Management raised its full-year adjusted EPS guidance to a range of $19.50 to $20.00. Net earnings for the quarter were up roughly 21% year-over-year.
Analysts Still Broadly Positive
Analyst sentiment has not shifted despite the recent slide. Oppenheimer raised its price target to $500 and kept an “outperform” rating in July. JPMorgan lifted its target to $516 with an “overweight” rating. Mizuho raised its target to $493 with an “outperform” call.
The consensus price target across analysts sits at $456.56, well above current trading levels. The average rating is “Moderate Buy,” with 19 buy ratings, 2 strong buys, and 6 holds.
Institutional ownership remains high at 87.86%. Arizona State Retirement System increased its stake by 1.5% in Q2, bringing its holdings to 251,862 units valued at roughly $104.7 million.
On the insider side, CEO Patrick Conway sold 1,169 units of UNH stock at an average price of $390.00 on August 21, a transaction totaling $455,910. Following the sale, Conway holds 15,328 units valued at approximately $5.98 million.
UNH’s 50-day moving average stands at $411.20, and its 200-day moving average is $365.42. The stock’s 1-year low is $255.96.
The quarterly dividend of $2.32 per unit will be paid on September 22 to shareholders on record as of September 14.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







